Abera Bioscience AB (NGM:ABERA)
7.60
-0.70 (-8.43%)
At close: Sep 8, 2025
Abera Bioscience AB Revenue
Abera Bioscience AB had revenue of 4.30M SEK in the quarter ending June 30, 2025, a decrease of -4.64%. This brings the company's revenue in the last twelve months to 15.72M, up 69.90% year-over-year. In the year 2024, Abera Bioscience AB had annual revenue of 14.63M with 479.60% growth.
Revenue (ttm)
15.72M
Revenue Growth
+69.90%
P/S Ratio
7.27
Revenue / Employee
3.14M
Employees
5
Market Cap
114.38M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.63M | 12.11M | 479.60% |
Dec 31, 2023 | 2.52M | 736.19K | 41.18% |
Dec 31, 2022 | 1.79M | 609.91K | 51.78% |
Dec 31, 2021 | 1.18M | 422.43K | 55.92% |
Dec 31, 2020 | 755.48K | -745.52K | -49.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Investor AB | 85.17B |
Atlas Copco AB | 173.03B |
AB Volvo | 500.08B |
EQT AB | 30.08B |
ASSA ABLOY AB | 152.95B |
Skandinaviska Enskilda Banken AB | 78.55B |
Sandvik AB | 121.46B |
Swedbank AB | 72.19B |